Cohortias joins the fight against COVID-19

April 8, 2020

As the situation gets harder, people all over the world unite in solidarity against this virus. We all need to do our part to contribute in the fight against it, that is why we are proud to announce that Cohortias has recently signed up to collaborate in research projects to develop a vaccine.

Share:

More Posts

Bio international

Cohortias – The BIO International Convention 2022.

For the first time in three years, the BIO International Convention will be back fully in person in San Diego, California.

type 2

Clinical Trial – Phase 1 of oral type 2 diabetes new therapy.

In the trial, GLY-200 was found to be well-tolerated across all tested dose levels without any safety signals detected.

booster

Clinical Trial – Phase 2 new covid-19 booster trial.

In the trial, vaccination with ABNCoV2 led to a substantial improvement in neutralizing antibodies against the Omicron variant.

osteoarthritis

First-in-Human – Phase 3 knee osteoarthritis trial.

The trial will evaluate the change in pain and function following subcutaneous injections of PPS versus placebo.

Send Us A Message